Thus, it must be considered that treatment with l‐citrulline may have unforeseen and potentially detrimental effects on the pathogenesis of pulmonary hypertension via differential impacts on the role of arginase I and/or arginase II in cell types other than endothelial cells by mechanisms not currently well understood. This evidence concerns the gene ARG2 and pulmonary arterial hypertension.